SCHEMBL15835577

SCHEMBL15835577

Brc1nc2ccccc2n1-c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.61
▸ HTT P42858 2/20 0.61
▸ TSHR P16473 2/20 0.49
▸ RECQL P46063 2/20 0.47
▸ ESR2 Q92731 2/20 0.47
▸ ESR1 P03372 1/20 0.47
▸ PRKACA P17612 1/20 0.46
▸ RPS6KB1 P23443 1/20 0.46
▸ GSK3B P49841 1/20 0.46
▸ ROCK1 Q13464 1/20 0.46
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ SLC22A12 Q96S37 1/20 0.45
▸ USP2 O75604 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ CRHBP P24387 1/20 0.45
▸ CRHR2 Q13324 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ GSR P00390 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31061815 1.00 MAPK1 (0.61) MAPK1HTTTSHRRECQLESR2
SCHEMBL29466048 0.83 KDM4E (0.50) MAPK1HTTTSHRRECQLESR2
SCHEMBL28705086 0.83 KDM4E (0.50) MAPK1HTTTSHRRECQLESR2
SCHEMBL18083403 0.82 TSHR (0.50) MAPK1HTTTSHRESR2ESR1
SCHEMBL31561665 0.81 FGFR1 (0.51) MAPK1HTTALDH1A1KDM4E
SCHEMBL29466021 0.80 HPGD (0.43) MAPK1HTTESR2ESR1NOS2
SCHEMBL28694895 0.80 HPGD (0.43) MAPK1HTTESR2ESR1NOS2
SCHEMBL16054504 0.80 RPS6KA5 (0.52) MAPK1HTTUSP2ALDH1A1KDM4E
SCHEMBL2309144 0.80 MAPK1 (0.61) MAPK1HTTTSHRRECQLESR2
SCHEMBL20776029 0.79 FGFR1 (0.50) MAPK1HTTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122010941-A Organic condensed ring compound and organic electroluminescent device prepared from same 湖北尚赛光电材料有限公司 2026-05-12 — — CN disclosed
US-12415949-B2 Compound, organic electroluminescent device, and display device SK INC. (KR) 2025-09-16 — — US disclosed
US-20250169357-A1 COMPOUND, ORGANIC LIGHT EMITTING DEVICE, AND DISPLAY DEVICE SK INC. (KR) 2025-05-22 — — US disclosed
CN-113135961-B Organometallic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device 三星电子株式会社 2025-01-21 — — CN disclosed
CN-118852194-A Organic electroluminescent compound and application thereof 宁波卢米蓝新材料有限公司 2024-10-29 — — CN disclosed
CN-111683942-B Compound, organic light-emitting device and display device SK 株式会社 2024-10-25 — — CN disclosed
US-20240334823-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT-EMITTING APPARATUS SAMSUNG DISPLAY CO., LTD. (KR) 2024-10-03 — — US disclosed
US-12052916-B2 Organometallic compound, organic light-emitting device including organometallic compound, and electronic apparatus including organic light-emitting apparatus SAMSUNG ELECTRONICS CO., LTD. (KR) 2024-07-30 — — US disclosed
US-11917913-B2 Substituted oxepines MERCK PATENT GMBH (DE) 2024-02-27 — — US disclosed
US-11917913-B2 Substituted oxepines MERCK PATENT GMBH (DE) 2024-02-27 — — US disclosed
WO-2017016667-A1 COMPOUNDS HAVING FLUORENE STRUCTURES MERCK PATENT GMBH (DE) 2017-02-02 — — WO disclosed
US-20160308146-A1 SUBSTITUTED OXEPINES MERCK PATENT GMBH (DE) 2016-10-20 — — US disclosed
US-20160308146-A1 SUBSTITUTED OXEPINES MERCK PATENT GMBH (DE) 2016-10-20 — — US disclosed
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2016-10-20 — — US disclosed
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2016-10-20 — — US disclosed
CN-105968076-A Spiral organic electroluminescent material and application thereof 中节能万润股份有限公司 2016-09-28 — — CN disclosed
CN-105936821-A Bisindenophenoxazine organic electroluminescence materials and application thereof 中节能万润股份有限公司 2016-09-14 — — CN disclosed
WO-2015090504-A2 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2015-06-25 — — WO disclosed
WO-2015082046-A2 SUBSTITUTED OXEPINES MERCK PATENT GMBH (DE) 2015-06-11 — — WO disclosed
WO-2014098455-A1 NOVEL ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME 주식회사 두산 (KR) 2014-06-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917913-B2 Substituted oxepines OXGR1, OXTR, OCIAD2 MAPK1 3381/4885HTT 403/4885TSHR 4405/4885
US-12415949-B2 Compound, organic electroluminescent device, and display device L1CAM, EML4, OCIAD2 MAPK1 2766/4885HTT 4268/4885TSHR 4181/4885
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 MAPK1 2561/4885HTT 247/4885TSHR 4030/4885
US-20240334823-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT-EMITTING APPARATUS L1CAM, MNS1, NOM1 MAPK1 1762/4885HTT 3770/4885TSHR 3473/4885
US-20160308146-A1 SUBSTITUTED OXEPINES OXGR1, OXTR, OCIAD2 MAPK1 3381/4885HTT 403/4885TSHR 4405/4885
US-12052916-B2 Organometallic compound, organic light-emitting device including organometallic compound, and electronic apparatus including organic light-emitting apparatus L1CAM, MNS1, NOM1 MAPK1 1762/4885HTT 3770/4885TSHR 3473/4885
US-20250169357-A1 COMPOUND, ORGANIC LIGHT EMITTING DEVICE, AND DISPLAY DEVICE ALDH1A2, L1CAM, OCIAD1 MAPK1 2952/4885HTT 4353/4885TSHR 4044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback